Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangbingdu Granules versus oseltamivir for influenza
ChiCTR1900027409Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Kangbingdu Granules and oseltamivir in influenza (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Time to symptom alleviation and Time to complete fever relief. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
Kangbingdu Granulesoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900027409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027409.